Get the Latest News | Annexus Health

Annexus Health’s New Solution Identifier Tool Guides Organizations to the Perfect Fit for Their Needs

January 24, 2025

Annexus Health has launched a new Solution Identifier tool to help organizations quickly determine which of the company’s innovative solutions—AssistPoint®, Adparo®, or AP Connect®—is right for them. “We developed our Solution Identifier because we understand that every organization has unique goals and challenges when it comes to patient assistance and access,” said Tim Koenig, VP…
Read more
The AstraZeneca Access 360™ Co-Pay Program Is Now Digitally Integrated With AssistPoint®

January 15, 2025

AstraZeneca is the latest life science company to partner with Annexus Health! Healthcare organizations can now enroll eligible patients into the Access 360 co-pay program directly within the AssistPoint software platform. To learn more about the Access 360 program, please visit www.myaccess360.com. AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development,…
Read more
Annexus Health Rings In 2025 By Surpassing $6 Billion in Patient Financial Assistance Awards Secured

January 9, 2025

Driven by a network of more than 4,200 sites of care now using the AssistPoint® platform to manage and secure assistance for patients CRANBERRY TOWNSHIP, Pa., Jan. 9, 2025 /PRNewswire/ – Annexus Health, Inc., the leading healthcare technology company that is revolutionizing the patient access journey through its innovative solutions, announced that its AssistPoint platform…
Read more
Annexus Health and the National Infusion Center Association (NICA) Renew Strategic Partnership to Advance Patient Affordability

December 16, 2024

The ongoing collaboration will further enhance efficiency and patient access to infusion therapy Annexus Health, Inc., the leading healthcare technology company that is revolutionizing the patient access journey through its innovative solutions, today announced it will continue its strategic partnership with the National Infusion Center Association (NICA) into 2025. The two like-minded organizations first partnered…
Read more
The LIBTAYO® (cemiplimab-rwlc) Patient Support Program, LIBTAYO Surround®, is Now Integrated with AssistPoint®

August 29, 2024

We are excited to announce that we have collaborated with Regeneron Pharmaceuticals, Inc. to make the LIBTAYO® (cemiplimab-rwlc) Patient Support Program, LIBTAYO Surround®, available to healthcare providers directly within AssistPoint®! Through collaborations like this, we continue to advance our mission, which is centered around making a difference in the lives of patients and their families.…
Read more
Survey Insights: Identifying Challenges and Solutions to Managing Patient Financial Assistance

August 26, 2024

To understand how to help ensure every eligible patient receives every available resource to afford their care, Annexus Health recently conducted two surveys of healthcare organization staff: one in collaboration with National Community Oncology Dispensing Association, Inc., and one in collaboration with Healthcare Advocate Summit. A total of 151 respondents shared their insights into how…
Read more
Annexus Health Surpasses $5 Billion in Patient Financial Assistance Awards

May 23, 2024

The AssistPoint® platform has been used to secure over $5 billion in patient financial assistance awards since 2018, helping patients across the country afford critical care without having to endure devastating financial hardship. Over $1 billion in patient financial assistance was secured through AssistPoint in the past 6 months alone. Licensed by over 140 healthcare…
Read more
MyNavCare™ Patient Support by Genmab is now digitally integrated with AssistPoint®

April 8, 2024

Genmab is the latest life science company to partner with Annexus Health. Healthcare organizations can enroll eligible patients in MyNavCare (once a prescribing decision has been made) directly within the AssistPoint software platform for the following: To learn more about MyNavCare Patient Support by Genmab, please visit mynavcare.com. Genmab is an international biotechnology company with…
Read more
ACCESS4Me™ for ROLVEDON® (eflapegrastim-xnst) injection is now digitally integrated with AssistPoint®

February 15, 2024

Assertio is the latest life science company to partner with Annexus Health. Healthcare organizations can now enroll eligible patients into ACCESS4ME™ for ROLVEDON® (eflapegrastim-xnst) injection directly within the AssistPoint software platform for the following: To learn more about ACCESS4Me, please visit ACCESS4Me.com. Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. They…
Read more

Cookie	Duration	Description
__cf_bm	30 minutes	Cloudflare set the cookie to support Cloudflare Bot Management.
_hjAbsoluteSessionInProgress	30 minutes	Hotjar sets this cookie to detect a user's first pageview session, which is a True/False flag set by the cookie.
drift_aid	1 year 1 month 4 days	Drift sets this cookie as a session identifier token. It is used to tie the visitor on your website to a current website session within the Drift system. This enables session-specific features, such as popping up a message only once during a 30 minute session to prevent a disruptive experience.
drift_campaign_refresh	30 minutes	Drift sets this cookie as a unique ID for the specific user. This allows the website to target the user with relevant offers through its chat functionality.
driftt_aid	1 year 1 month 4 days	Drift sets this cookie as an anonymous identifier token. As people come onto the site, they will get this cookie.

Cookie	Duration	Description
_ga	1 year 1 month 4 days	Google Analytics sets this cookie to calculate visitor, session and campaign data and track site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognise unique visitors.
_ga_*	1 year 1 month 4 days	Google Analytics sets this cookie to store and count page views.
_gat_gtag_UA_*	1 minute	Google Analytics sets this cookie to store a unique user ID.
_gid	1 day	Google Analytics sets this cookie to store information on how visitors use a website while also creating an analytics report of the website's performance. Some of the collected data includes the number of visitors, their source, and the pages they visit anonymously.
_hjFirstSeen	30 minutes	Hotjar sets this cookie to identify a new user’s first session. It stores the true/false value, indicating whether it was the first time Hotjar saw this user.
_hjRecordingEnabled	never	Hotjar sets this cookie when a Recording starts and is read when the recording module is initialized, to see if the user is already in a recording in a particular session.
_hjRecordingLastActivity	never	Hotjar sets this cookie when a user recording starts and when data is sent through the WebSocket.
CONSENT	2 years	YouTube sets this cookie via embedded YouTube videos and registers anonymous statistical data.
pardot	past	The pardot cookie is set while the visitor is logged in as a Pardot user. The cookie indicates an active session and is not used for tracking.

Cookie	Duration	Description
VISITOR_INFO1_LIVE	5 months 27 days	YouTube sets this cookie to measure bandwidth, determining whether the user gets the new or old player interface.
YSC	session	Youtube sets this cookie to track the views of embedded videos on Youtube pages.

Cookie	Duration	Description
_hjIncludedInSessionSample_3267021	2 minutes	Description is currently not available.
_hjSession_3267021	30 minutes	Description is currently not available.
_hjSessionUser_3267021	1 year	Description is currently not available.
lpv1024441	30 minutes	Description is currently not available.
visitor_id1024441	1 year	Description is currently not available.
visitor_id1024441-hash	1 year	Description is currently not available.

Company news